Top Stories
-
A new study shows how modifications to the tau protein may influence the different ways it can misfold in the brain, which is closely linked to the type of neurodegenerative disease that develops.
Topic
-
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
Topic
-
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
Topic
-
The source of essential tremor—involuntary, rhythmic trembling—has been elusive, but a new study points to abnormal electrical activity in the base of the brain.
Topic
Latest News
- January 22, 2019
A new study by Columbia researchers suggests aspirin may lower stroke risk among middle-aged women with a history of preeclampsia.
Topic
- December 28, 2018
Columbia neurologists and engineers are developing what would be the first wearable diagnostic device for traumatic brain injury.
Topic
- December 17, 2018
A new study shows how cellular “housekeeping” protects some neurons against the toxic proteins of Alzheimer’s disease and suggests new treatment possibilities.
Topic
- November 28, 2018
Increasingly, transformative therapies are being launched via startups emerging from university research labs, including those at Columbia’s Vagelos College of Physicians and Surgeons.
Topic
- November 26, 2018
Scientists initially believed Alzheimer's would be a simple, straightforward problem to solve, but now Columbia researchers are looking for unusual and untried solutions.
Topic
- November 19, 2018
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Topic
- September 26, 2018
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
Topic
- September 18, 2018
A newly discovered function for the ApoE4 gene, the strongest genetic risk factor for Alzheimer’s disease, may help explain how the gene causes cognitive decline.
Topic
- September 18, 2018
A new anti-inflammatory drug may offer hope for people with a progressive form of MS. In a phase 2 trial, the drug slowed brain atrophy in people with the disease.
Topic
- September 5, 2018
A new study suggests that, among older adults, cognitive performance changes with the seasons and peaks in late summer.
Topic
